Carriers have been described in patients with BC,7, 8 OC,9 and pancreatic10, 11, 12 cancers, a tumor spectrum characteristic for carriers of GPVs in established FA cancer predisposition genes (including BRCA1, BRCA2). This evidence concerns the gene BRCA1 and breast cancer.